BridgeMD
Compares treatment options for HIV Infections
Official title Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique
ClinicalTrials.gov ID: NCT06326294
What this study is testing
- What it's testing
- Given that WLWH are more likely to develop persistent HPV infection and CC, effective screening and the management and treatment of pre-cancerous cervical abnormalities is critical to decrease the global burden of cervical cancer. The vast majority of WLWH live in SSA, where resources are more constrained.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 49, women only
You may be able to join if
- ages 25-49 years;
- confirmed HIV infection;
- physically and mentally willing and able to participate in the study, and provide informed consent.
You likely can't join if
- currently pregnant or \<6 weeks post-partum;
- had a hysterectomy and no longer have a cervix;
- a history of cervical cancer or treatment for cervical abnormalities; and
- any medical, psychiatric, or other condition that would interfere with protocol adherence, assessment of safety, and/or ability/competence to provide...
The study team makes the final eligibility decision.
Where it's taking place
- Maputo, Mozambique
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 25 years to 49 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Maputo, Mozambique. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.